Industry Focus

The FDA approved the world's first CAR-T therapy on Wednesday, one month ahead of schedule, and only days after Gilead Sciences announced it’s buying CAR-T powerhouse Kite Pharma in a deal valued at $11.9 billion. 

 

Direct download: 20170830_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST

1